Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis.

Takeda T, Banno K, Yanokura M, Adachi M, Iijima M, Kunitomi H, Nakamura K, Iida M, Nogami Y, Umene K, Masuda K, Kobayashi Y, Yamagami W, Hirasawa A, Tominaga E, Susumu N, Aoki D.

Genes (Basel). 2016 Oct 14;7(10). pii: E86.

2.

Deficient mismatch repair: Read all about it (Review).

Richman S.

Int J Oncol. 2015 Oct;47(4):1189-202. doi: 10.3892/ijo.2015.3119. Review.

3.

Hereditary Colorectal Cancer: Genetics and Screening.

Brosens LA, Offerhaus GJ, Giardiello FM.

Surg Clin North Am. 2015 Oct;95(5):1067-80. doi: 10.1016/j.suc.2015.05.004. Review.

4.

Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers.

Egoavil C, Alenda C, Castillejo A, Paya A, Peiro G, Sánchez-Heras AB, Castillejo MI, Rojas E, Barberá VM, Cigüenza S, Lopez JA, Piñero O, Román MJ, Martínez-Escoriza JC, Guarinos C, Perez-Carbonell L, Aranda FI, Soto JL.

PLoS One. 2013 Nov 7;8(11):e79737. doi: 10.1371/journal.pone.0079737.

5.

Extracolonic manifestations of lynch syndrome.

Bansidhar BJ.

Clin Colon Rectal Surg. 2012 Jun;25(2):103-10. doi: 10.1055/s-0032-1313781.

6.

History and pathogenesis of lynch syndrome.

Bansidhar BJ, Silinsky J.

Clin Colon Rectal Surg. 2012 Jun;25(2):63-6. doi: 10.1055/s-0032-1313776.

7.

Promoter methylation of candidate genes associated with familial testicular cancer.

Mirabello L, Kratz CP, Savage SA, Greene MH.

Int J Mol Epidemiol Genet. 2012;3(3):213-27.

8.

Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry.

Ward RL, Dobbins T, Lindor NM, Rapkins RW, Hitchins MP.

Genet Med. 2013 Jan;15(1):25-35. doi: 10.1038/gim.2012.91.

9.

Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer.

Hansmann T, Pliushch G, Leubner M, Kroll P, Endt D, Gehrig A, Preisler-Adams S, Wieacker P, Haaf T.

Hum Mol Genet. 2012 Nov 1;21(21):4669-79. doi: 10.1093/hmg/dds308.

10.

MLH1 methylation screening is effective in identifying epimutation carriers.

Pineda M, Mur P, Iniesta MD, Borràs E, Campos O, Vargas G, Iglesias S, Fernández A, Gruber SB, Lázaro C, Brunet J, Navarro M, Blanco I, Capellá G.

Eur J Hum Genet. 2012 Dec;20(12):1256-64. doi: 10.1038/ejhg.2012.136.

11.

MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.

Gausachs M, Mur P, Corral J, Pineda M, González S, Benito L, Menéndez M, Espinàs JA, Brunet J, Iniesta MD, Gruber SB, Lázaro C, Blanco I, Capellá G.

Eur J Hum Genet. 2012 Jul;20(7):762-8. doi: 10.1038/ejhg.2011.277.

12.

Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting.

Bellcross CA, Bedrosian SR, Daniels E, Duquette D, Hampel H, Jasperson K, Joseph DA, Kaye C, Lubin I, Meyer LJ, Reyes M, Scheuner MT, Schully SD, Senter L, Stewart SL, St Pierre J, Westman J, Wise P, Yang VW, Khoury MJ.

Genet Med. 2012 Jan;14(1):152-62. doi: 10.1038/gim.0b013e31823375ea.

13.

Monozygotic twins discordant for constitutive BRCA1 promoter methylation, childhood cancer and secondary cancer.

Galetzka D, Hansmann T, El Hajj N, Weis E, Irmscher B, Ludwig M, Schneider-Rätzke B, Kohlschmidt N, Beyer V, Bartsch O, Zechner U, Spix C, Haaf T.

Epigenetics. 2012 Jan 1;7(1):47-54. doi: 10.4161/epi.7.1.18814.

14.

Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry.

Levine AJ, Win AK, Buchanan DD, Jenkins MA, Baron JA, Young JP, Long TI, Weisenberger DJ, Laird PW, McCall RL, Duggan DJ, Haile RW.

Cancer Prev Res (Phila). 2012 Feb;5(2):328-35. doi: 10.1158/1940-6207.CAPR-11-0419.

15.

Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.

Moore LE, Nickerson ML, Brennan P, Toro JR, Jaeger E, Rinsky J, Han SS, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Schmidt LS, Lenz P, Karami S, Linehan WM, Merino M, Chanock S, Boffetta P, Chow WH, Waldman FM, Rothman N.

PLoS Genet. 2011 Oct;7(10):e1002312. doi: 10.1371/journal.pgen.1002312.

16.

Chromium in drinking water: sources, metabolism, and cancer risks.

Zhitkovich A.

Chem Res Toxicol. 2011 Oct 17;24(10):1617-29. doi: 10.1021/tx200251t. Review.

17.

Dark matters in AMD genetics: epigenetics and stochasticity.

Hjelmeland LM.

Invest Ophthalmol Vis Sci. 2011 Mar 1;52(3):1622-31. doi: 10.1167/iovs.10-6765. Review. No abstract available.

18.

Systematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolution.

Potapova A, Albat C, Hasemeier B, Haeussler K, Lamprecht S, Suerbaum S, Kreipe H, Lehmann U.

BMC Biotechnol. 2011 Jan 14;11:6. doi: 10.1186/1472-6750-11-6.

19.

DNA mismatch repair and infertility.

Mukherjee S, Ridgeway AD, Lamb DJ.

Curr Opin Urol. 2010 Nov;20(6):525-32. doi: 10.1097/MOU.0b013e32833f1c21. Review.

20.

De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.

Goel A, Nguyen TP, Leung HC, Nagasaka T, Rhees J, Hotchkiss E, Arnold M, Banerji P, Koi M, Kwok CT, Packham D, Lipton L, Boland CR, Ward RL, Hitchins MP.

Int J Cancer. 2011 Feb 15;128(4):869-78. doi: 10.1002/ijc.25422.

Items per page

Supplemental Content

Support Center